Rezūm is a safe and effective minimally invasive treatment designed to relieve BPH symptoms by reducing the extra prostate tissue causing the problems you are experiencing.
Rezūm is a transurethral RF thermal therapy to treat benign prostatic hyperplasia (BPH) that can be performed in a clinic or out-patient setting. Using a hand-held device, Rezūm delivers radiofrequency generated thermal therapy, in the form of water vapor, directly to the extra prostate tissue that is causing symptoms such as frequency, urgency, irregular flow, weak stream, straining and getting up at night to urinate.
*transurethral needle ablation describes the minimally invasive procedure in which a device is inserted into the urethra.
- Men who have elected to discontinue or who have chosen not to take BPH medication
- Men who are not interested in other minimally invasive or surgical BPH procedures
- Men who have indicated they aren’t bothered enough by their symptoms to elect an invasive surgical procedure
Your urologist will consult with you to determine if Rezūm is a good treatment option for you based on your symptoms and personal treatment goals. The Rezūm System is indicated for men 50 years and older with a prostate volume of ≥ 30cm3 and ≤80cm3. The prostate is made up of several zones and/or regions. It is important to treat all of the extra tissue in your prostate in order to reduce your symptoms. Unlike other therapies, the Rezūm System is also indicated for treatment of prostate with hyperplasia of the central zone and/or a median lobe. The use of the Rezūm System is contraindicated for patients with a urinary sphincter implant or who have a penile prosthesis.
The main insurance companies of BUPA, AXA and WPA have all approved this treatment. Please speak to your insurer to check the treatment is an option on your policy.
Yes, this is an option and the hospital will put together a Self Pay Package price for you. The typical cost of this procedure is around £4500 but is dependent on the hospital and what is included in the package price.
To access summaries of the primary published data on Rezūm, please visit the Rezūm Clinical Data page.
The primary publication for information on clinical results, including adverse events, is in the publication entitled:
“Convective radiofrequency water vapor thermal therapy with Rezūm System: Durable two- year results of randomized controlled and prospective crossover studies for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia.”
For more information on the Rezūm device and the clinical data that was used to gain product clearance from the FDA, please see the Rezūm Instructions for Use.